July 14, 2013
I worked at Sigma Aldrich for 4 years in a quality group that supported clients with biopharmaceutical products in clinical trials. It always scared me that the company management was always pushing "to cut corners" in order to save money without making an accurate assessment of how the quality, efficacy and safety of that product could be compromised. I worked 7 years for J&J prior to Sigma, and J&J never took a chance to do anything that could compromised the safety, efficacy and quality of their drugs. Of course J&J is a gigantic pharmaceutical drug, and was always under the FDA radar.